方正证券研报指出，迈瑞医疗是国内医疗器械龙头，三大业务板块稳健增长，在“三瑞”数智化解决方案赋能下，持续拓展国内外市场，尤其是加速出海产品矩阵的高端升级和高端客户突破，有望持续高增长，加之微创外科、动物医疗、心血管等种子业务快速发展，整体营收规模行业领先，并在高端化+AI数智化+国际化的多轮驱动下，公司有望持续提升国内外市场份额，实现稳健业绩增长和较高的盈利水平，具备可观的业绩成长确定性和可及空间。维持“强烈推荐”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.